FR2762787B1 - ANTI-HELICOBACTER VACCINE COMPOSITION COMPRISING A TH1 ADJUVANT - Google Patents

ANTI-HELICOBACTER VACCINE COMPOSITION COMPRISING A TH1 ADJUVANT

Info

Publication number
FR2762787B1
FR2762787B1 FR9705608A FR9705608A FR2762787B1 FR 2762787 B1 FR2762787 B1 FR 2762787B1 FR 9705608 A FR9705608 A FR 9705608A FR 9705608 A FR9705608 A FR 9705608A FR 2762787 B1 FR2762787 B1 FR 2762787B1
Authority
FR
France
Prior art keywords
adjuvant
vaccine composition
helicobacter vaccine
helicobacter
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR9705608A
Other languages
French (fr)
Other versions
FR2762787A1 (en
Inventor
Bruno Guy
Jean Haensler
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Pasteur SA
Original Assignee
Pasteur Merieux Serum et Vaccines SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to FR9705608A priority Critical patent/FR2762787B1/en
Application filed by Pasteur Merieux Serum et Vaccines SA filed Critical Pasteur Merieux Serum et Vaccines SA
Priority to AU76584/98A priority patent/AU750379B2/en
Priority to BR9809381-9A priority patent/BR9809381A/en
Priority to KR1019997010042A priority patent/KR20010020418A/en
Priority to CA002287976A priority patent/CA2287976A1/en
Priority to PCT/FR1998/000875 priority patent/WO1998048836A1/en
Priority to JP54668498A priority patent/JP2002505665A/en
Priority to EP98924360A priority patent/EP0979100A1/en
Publication of FR2762787A1 publication Critical patent/FR2762787A1/en
Application granted granted Critical
Publication of FR2762787B1 publication Critical patent/FR2762787B1/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/105—Delta proteobacteriales, e.g. Lawsonia; Epsilon proteobacteriales, e.g. campylobacter, helicobacter
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55577—Saponins; Quil A; QS21; ISCOMS
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
FR9705608A 1997-04-30 1997-04-30 ANTI-HELICOBACTER VACCINE COMPOSITION COMPRISING A TH1 ADJUVANT Expired - Fee Related FR2762787B1 (en)

Priority Applications (8)

Application Number Priority Date Filing Date Title
FR9705608A FR2762787B1 (en) 1997-04-30 1997-04-30 ANTI-HELICOBACTER VACCINE COMPOSITION COMPRISING A TH1 ADJUVANT
BR9809381-9A BR9809381A (en) 1997-04-30 1998-04-30 Anti-helicobacter vaccine composition comprising a th1-type adjuvant
KR1019997010042A KR20010020418A (en) 1997-04-30 1998-04-30 Anti-Helicobacter vaccine composition comprising a Th1-type adjuvant
CA002287976A CA2287976A1 (en) 1997-04-30 1998-04-30 Anti-helicobacter vaccine composition comprising a th1 adjuvant
AU76584/98A AU750379B2 (en) 1997-04-30 1998-04-30 Anti-helicobacter vaccine composition comprising a Th1 adjuvant
PCT/FR1998/000875 WO1998048836A1 (en) 1997-04-30 1998-04-30 Anti-helicobacter vaccine composition comprising a th1 adjuvant
JP54668498A JP2002505665A (en) 1997-04-30 1998-04-30 Anti-Helicobacter vaccine composition containing Th1-type adjuvant
EP98924360A EP0979100A1 (en) 1997-04-30 1998-04-30 ANTI-$i(HELICOBACTER) VACCINE COMPOSITION COMPRISING A TH1 ADJUVANT

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9705608A FR2762787B1 (en) 1997-04-30 1997-04-30 ANTI-HELICOBACTER VACCINE COMPOSITION COMPRISING A TH1 ADJUVANT

Publications (2)

Publication Number Publication Date
FR2762787A1 FR2762787A1 (en) 1998-11-06
FR2762787B1 true FR2762787B1 (en) 2000-10-06

Family

ID=9506651

Family Applications (1)

Application Number Title Priority Date Filing Date
FR9705608A Expired - Fee Related FR2762787B1 (en) 1997-04-30 1997-04-30 ANTI-HELICOBACTER VACCINE COMPOSITION COMPRISING A TH1 ADJUVANT

Country Status (1)

Country Link
FR (1) FR2762787B1 (en)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3521994A1 (en) * 1985-06-20 1987-01-02 Bayer Ag N- (2-AMINOACYLAMIDO-2-DESOXY-HEXOSYL) -AMIDES, CARBAMATES AND UREAS, METHODS FOR THE PRODUCTION THEREOF AND THEIR USE IN MEDICINAL PRODUCTS
CA1331443C (en) * 1987-05-29 1994-08-16 Charlotte A. Kensil Saponin adjuvant
US5283185A (en) * 1991-08-28 1994-02-01 University Of Tennessee Research Corporation Method for delivering nucleic acids into cells
US6290962B1 (en) * 1992-11-03 2001-09-18 Oravax, Inc. Urease-based vaccine and treatment for helicobacter infection
FR2732605B1 (en) * 1995-04-07 1997-05-16 Pasteur Merieux Serums Vacc COMPOSITION FOR INDUCING MUCOSAL IMMUNE RESPONSE

Also Published As

Publication number Publication date
FR2762787A1 (en) 1998-11-06

Similar Documents

Publication Publication Date Title
NO20003302L (en) Vaccine
HRP980187B1 (en) Influenza vaccine
GB9712347D0 (en) Vaccine
GB9718901D0 (en) Vaccine
GB9711990D0 (en) Vaccine
GB9726555D0 (en) Vaccine
GB9720585D0 (en) Vaccine
BR9711853A (en) Vaccines
NO20004758L (en) vaccine Composition
HUP0100058A3 (en) Vaccines with an ltb adjuvant
ID17860A (en) VACCINE COMPOSITION
IS5694A (en) vaccine
IS5967A (en) Oral vaccine for diarrhea
FR2762787B1 (en) ANTI-HELICOBACTER VACCINE COMPOSITION COMPRISING A TH1 ADJUVANT
ZA982763B (en) Vaccines
GB9718616D0 (en) Oral vaccine
BR1100968A (en) Subunit vaccine formulation
GB9714333D0 (en) Rotavirus vaccine formulations
GB9718902D0 (en) Vaccine
GB9717423D0 (en) Vaccine
GB9720982D0 (en) Vaccine
BR1100918A (en) Vaccine composition containing adjuvants
GB9705460D0 (en) Polynucleotide vaccine formulations
GB9702920D0 (en) Vaccines
KR970060699U (en) Periodontal Disease Adjuvant Chair

Legal Events

Date Code Title Description
TP Transmission of property
ST Notification of lapse

Effective date: 20051230